Product Information

AMLODIPINE-VALSARTAN 10-320 MG is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.4495 per EA under NDC 33342028207. Its NADAC has been published 77 times since Mar 5, 2025.

FDA first approved this application on Oct 11, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE-VALSARTAN 10-320 MG

amlodipine and valsartan
$0.4495per EA

Strength

10; 320 mg/1; mg/1

NDC

33342028207

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207292

FDA Approved

10/11/2024

TE Code

AB

On Market Since

10/16/2024

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for AMLODIPINE-VALSARTAN 10-320 MG has been published 77 times since Mar 5, 2025, and over the history we have for it it has declined 30.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4495 per EA
All-time high$0.6623 (Oct 15, 2025)
All-time low$0.4495 (Aug 19, 2026)
52-week high$0.6623
52-week low$0.4495
Median price$0.6457
Average price$0.6311
Largest weekly change-12.9% (Jul 22, 2026)
Weeks tracked77
Tracking sinceMar 5, 2025

Price History

1W

-6.3%

1M

-6.3%

3M

-27.5%

6M

-30.3%

1Y

-31.8%

3Y

N/A

5Y

N/A

All

-30.6%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of AMLODIPINE-VALSARTAN 10-320 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-VALSARTAN 10-320 MG, manufactured by Macleods Pharmaceuticals Limited, is $0.4495 per EA (NDC 33342028207), effective Aug 19, 2026.

How has the price of AMLODIPINE-VALSARTAN 10-320 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-VALSARTAN 10-320 MG has declined 30.6%. It has been tracked across 77 weekly CMS publications since Mar 5, 2025.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-VALSARTAN 10-320 MG?

Since Mar 5, 2025, the NADAC for AMLODIPINE-VALSARTAN 10-320 MG has ranged from a low of $0.4495 (Aug 19, 2026) to a high of $0.6623 (Oct 15, 2025), with a median of $0.6457 per EA.

Are there cheaper alternatives to AMLODIPINE-VALSARTAN 10-320 MG?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-VALSARTAN 10-320 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures AMLODIPINE-VALSARTAN 10-320 MG?

AMLODIPINE-VALSARTAN 10-320 MG (NDC 33342028207) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.